These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31613195)

  • 21. Functional studies in substance abuse: imaging and beyond.
    Levin JM; Kaufman MJ
    J Nucl Med; 1995 Jul; 36(7):1298-300. PubMed ID: 7790959
    [No Abstract]   [Full Text] [Related]  

  • 22. Brain imaging in nonhuman primates: insights into drug addiction.
    Nader MA; Czoty PW
    ILAR J; 2008; 49(1):89-102. PubMed ID: 18172336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET imaging studies in drug abuse.
    Fowler JS; Volkow ND
    J Toxicol Clin Toxicol; 1998; 36(3):163-74. PubMed ID: 9656971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From rats to humans and return: testing addiction hypotheses by combined PET imaging and self-reported measures of psychostimulant effects. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'.
    Di Chiara G
    Behav Pharmacol; 2002 Sep; 13(5-6):371-7. PubMed ID: 12394413
    [No Abstract]   [Full Text] [Related]  

  • 25. Conversation with Michael Kuhar.
    Kuhar M
    Addiction; 2010 Apr; 105(4):593-600. PubMed ID: 20403012
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuropsychiatric disorders: investigation of schizophrenia and substance abuse.
    Volkow ND; Fowler JS
    Semin Nucl Med; 1992 Oct; 22(4):254-67. PubMed ID: 1439871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systems and control theory approach to dynamic neurotransmitter balance in narcotic addiction and narcotic antagonism.
    Kaufman JJ; Koski WS; Peat K
    Life Sci; 1975 Jul; 17(1):83-4. PubMed ID: 238091
    [No Abstract]   [Full Text] [Related]  

  • 28. From neurobiology to treatment: progress against addiction.
    Nestler EJ
    Nat Neurosci; 2002 Nov; 5 Suppl():1076-9. PubMed ID: 12403990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative positron emission tomography in brain research.
    Heurling K; Leuzy A; Jonasson M; Frick A; Zimmer ER; Nordberg A; Lubberink M
    Brain Res; 2017 Sep; 1670():220-234. PubMed ID: 28652218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights from recent positron emission tomographic studies of drug abuse and dependence.
    Chang L; Haning W
    Curr Opin Psychiatry; 2006 May; 19(3):246-52. PubMed ID: 16612209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of cross-species PET imaging to assess neurotransmitter release in brain.
    Finnema SJ; Scheinin M; Shahid M; Lehto J; Borroni E; Bang-Andersen B; Sallinen J; Wong E; Farde L; Halldin C; Grimwood S
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4129-57. PubMed ID: 25921033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failed PET Application Attempts in the Past, Can We Avoid Them in the Future?
    Cheng G; Werner TJ; Newberg A; Alavi A
    Mol Imaging Biol; 2016 Dec; 18(6):797-802. PubMed ID: 27730470
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo tomographic imaging studies of neurodegeneration and neuroprotection: a review.
    Waterhouse RN; Zhao J
    Methods Mol Biol; 2007; 399():215-33. PubMed ID: 18309935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging the roles of the amygdala in drug addiction.
    Kilts CD
    Psychopharmacol Bull; 2001; 35(1):84-94. PubMed ID: 12397873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural correlates of hot and cold executive functions in polysubstance addiction: association between neuropsychological performance and resting brain metabolism as measured by positron emission tomography.
    Moreno-López L; Stamatakis EA; Fernández-Serrano MJ; Gómez-Río M; Rodríguez-Fernández A; Pérez-García M; Verdejo-García A
    Psychiatry Res; 2012; 203(2-3):214-21. PubMed ID: 22959812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography.
    Muehllehner G; Karp JS
    Phys Med Biol; 2006 Jul; 51(13):R117-37. PubMed ID: 16790899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nora Volkow--challenging the myths about drug addiction.
    Shetty P
    Lancet; 2011 Aug; 378(9790):477. PubMed ID: 21821175
    [No Abstract]   [Full Text] [Related]  

  • 38. Positron emission tomography in psychiatric disorders.
    Newberg AB; Moss AS; Monti DA; Alavi A
    Ann N Y Acad Sci; 2011 Jun; 1228():E13-25. PubMed ID: 22239386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?
    Ballinger JR
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2340. PubMed ID: 18850098
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurobiology of addiction: insight from neurochemical imaging.
    Urban NB; Martinez D
    Psychiatr Clin North Am; 2012 Jun; 35(2):521-41. PubMed ID: 22640769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.